Shijiazhuang Yiling Pharmaceutical Co., Ltd. Class ASZSE: 002603

Shijiazhuang Yiling Pharmaceutical Co: Net profit soared 80.33% to ¥1.00 billion despite a 7.82% revenue decline

· Issued by Shijiazhuang Yiling Pharmaceutical Co., Ltd. Class A

Revenue declined 7.82% year-over-year to ¥5.87 billion, but net profit attributable to shareholders jumped 80.33% to ¥1.00 billion, driven by cost control and non-recurring gains. Operating cash flow rose 296.19% to ¥1.28 billion.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Earlier from Shijiazhuang Yiling Pharmaceutical Co., Ltd. Class A

All Shijiazhuang Yiling Pharmaceutical Co., Ltd. Class A news releases